Clinical Trials Logo

Clinical Trial Summary

Patients with acute myocardial infarction (AMI) are in critical condition. When primary percutaneous coronary intervention (PCI) was performing, no-reflow, reperfusion injury,heart failure, heart rupture, malignant arrhythmia maybe happen. It was reported remote ischemic preconditioning (RIPC) may play an effective endogenous cardiac protection. This study will investigate whether once RIPC before primary PCI or long-term RIPC can improve AMI patients short-term and long-term (1 year) prognosis. 400 STEMI patients undergoing primary PCI were randomly divided into 3 groups: long-term RIPC group (once preoperative RIPC and once RIPC/day after PCI), preoperative RIPC group (once preoperative RIPC), control group (without RIPC). Cardiac troponin (TNI), high-sensitivity C-reactive protein (hsCRP), adenosine, vascular endothelial growth factor (VEGF), hypoxia inducible factor-1 (HIF-1), echocardiography and magnetic resonance (MR)were detected 1 day, 1 month and 1 year after PCI. Patients will be followed up by telephone at the end of one year. The major adverse cardiovascular events (MACE) include cardiovascular death, spontaneous myocardial infarction, unplanned revascularization and stroke.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT03018873
Study type Interventional
Source Xuanwu Hospital, Beijing
Contact Liu zhi, doctor
Phone 13911517967
Email xwyy168@sina.com
Status Not yet recruiting
Phase N/A
Start date December 2016

See also
  Status Clinical Trial Phase
Recruiting NCT05759078 - Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion Phase 4
Completed NCT06408636 - Prognostic Role of LA Strain in Acute Myocardial Infarction
Recruiting NCT06038994 - Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction
Recruiting NCT04968808 - Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI) N/A
Completed NCT03338504 - Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction
Recruiting NCT03317691 - The ALERT-Pilot Study N/A
Active, not recruiting NCT05077683 - Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF Phase 3
Recruiting NCT03957005 - Cardiovascular Risk Assessment Model in Patients With MI
Enrolling by invitation NCT05955950 - Gratitude Intervention in Promoting Self-care in Patients With Myocardial Infarction N/A
Active, not recruiting NCT06141252 - Benefit of Hypothermia in OHCA Complicating AMI N/A
Not yet recruiting NCT04560023 - Effectiveness of Multimedia Exposure in Patients Transferred to Hospital Suffering From Acute Myocardial Infarction N/A
Recruiting NCT03809689 - Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET N/A
Completed NCT05118009 - Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE) N/A
Active, not recruiting NCT04753749 - Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy N/A
Completed NCT04769219 - Secondary Prevention Education After Acute Myocardial Infarction N/A
Active, not recruiting NCT05350969 - Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction Phase 2
Recruiting NCT05999110 - Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR) N/A
Completed NCT04167904 - Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction
Not yet recruiting NCT04989777 - IABP In AMI Patients With SCAI-B Study N/A
Recruiting NCT05043610 - MSCs for Prevention of MI-induced HF Phase 3